Finance

Lists
Why is ENOV up 4,16%?
Dive Deeper
ENOV:NYSE
Enovis Corp
19,01 $
+4,16%
(+0,76) 1D
13 қаз., 15:36:11 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ENOV...
Open
18,50 $
High
19,07 $
Low
18,18 $
Mkt. cap
1,10 млрд
Avg. vol.
1,96 млн
Volume
580,89 м.
52-wk high
34,28 $
52-wk low
16,70 $
EPS
-19,27 $
Beta
1,14
Shares outstanding
57,67 млн
No. of employees
8 мың
Open
18,50 $
High
19,07 $
Low
18,18 $
Mkt. cap
1,10 млрд
Avg. vol.
1,96 млн
Volume
580,89 м.
52-wk high
34,28 $
52-wk low
16,70 $
EPS
-19,27 $
Beta
1,14
Shares outstanding
57,67 млн
No. of employees
8 мың
News stories
From web sources and news partners
Profile
Enovis Corporation is a medical technology company with a focus in orthopedics. The company was founded by brothers Mitchell and Steven Rales as the Colfax Corporation in 1995. Enovis is headquartered in Dallas, Texas and is listed on the NYSE as ENOV. The company has over 8,000 employees operating at 30 sites around the world. Wikipedia
About Enovis Corp
CEOMatthew L. Trerotola
Employees7,8 мың
Founded1995
HeadquartersWilmington, Делавэр, Америка Құрама Штаттары
SectorMedical device
Websiteenovis.com
Analyst ratings
Based on 12 analysts giving stock ratings to ENOV in the past 3 months
Strong buy
Buy
11
Hold
1
Sell
0
12-month forecast
Based on 12 Wall Street analysts offering 12 month price targets for ENOV in the last 3 months.
Highest
Current 19,01 $
47,00 $ (+147,24%)
Average
36,55 $ (+92,27%)
Lowest
27,00 $ (+42,03%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Matson
Needham
Buy
Maintained
34,00 $
+78,9%
10/12/2026
Patrick Wood
UBS
Buy
Maintained
44,00 $
+131,5%
10/05/2026
Ryan Zimmerman
BTIG
Buy
Maintained
36,00 $
+89,4%
10/02/2026
Larry Biegelsen
Wells Fargo
Buy
Maintained
33,00 $
+73,6%
09/08/2026
Caitlin Cronin
Canaccord Genuity
Buy
Reiterated
45,00 $
+136,7%
09/01/2026
Caitlin Roberts
Canaccord Genuity
Buy
Reiterated
45,00 $
+136,7%
09/01/2026
David Turkaly
Citizens JMP
Buy
Maintained
47,00 $
+147,2%
09/02/2026
Vik Chopra
BMO Capital
Buy
Reiterated
27,00 $
+42%
09/01/2026
Keith Hinton
Freedom Capital Markets
Buy
Maintained
36,00 $
+89,4%
09/01/2026
Steven Lichtman
William Blair
Buy
Maintained
-
-
08/14/2026
Robbie Marcus
J.P. Morgan
Hold
Maintained
28,00 $
+47,3%
08/10/2026
Vijay Kumar
Evercore ISI
Buy
Maintained
32,00 $
+68,3%
08/07/2026
Rong Li
Jefferies
Buy
Reiterated
40,00 $
+110,4%
07/14/2026
Unknown Analyst
Jefferies
Buy
Reiterated
40,00 $
+110,4%
07/14/2026
Unknown Analyst
BMO Capital
Buy
Initiated
29,00 $
+52,6%
07/09/2026
Jeff Johnson
Robert W. Baird
Buy
Maintained
37,00 $
+94,6%
05/08/2026
Last report
2026 ж. 06 там.
Fiscal period
Q2 2026
0,90 $ / 0,85 $
+6,34%beat
Revenue / Est. (USD)
582,78 млн / 581,84 млн
+0,16%beat
Fiscal Q2 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
2025 ж. қаз.
2025 ж. жел.
2026 ж. сәу.
2026 ж. шіл.
Revenue
548,91 млн
575,76 млн
589,15 млн
582,78 млн
Cost of goods sold
218,50 млн
222,69 млн
223,67 млн
223,53 млн
Cost of revenue
218,50 млн
222,69 млн
223,67 млн
223,53 млн
Research and development expenses
29,74 млн
31,36 млн
31,53 млн
31,69 млн
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
245,42 млн
249,84 млн
270,58 млн
261,61 млн
Operating expense
318,85 млн
326,38 млн
344,02 млн
334,86 млн
Total operating expenses
537,35 млн
549,08 млн
567,69 млн
558,39 млн
Operating income
11,56 млн
26,68 млн
21,46 млн
24,39 млн
Other non operating income
448,00 м.
1,93 млн
3,27 млн
-1,91 млн
EBT including unusual items
-566,87 млн
-509,55 млн
634,00 м.
7,46 млн
EBT excluding unusual items
3,18 млн
21,10 млн
15,57 млн
14,44 млн
Income tax expense
4,00 млн
9,26 млн
9,04 млн
8,50 млн
Effective tax rate
-0,71%
-1,82%
1 426,66%
113,88%
Other operating expenses
-
-
-
-
Net income
-571,15 млн
-520,59 млн
-8,76 млн
-1,19 млн
Net profit margin
-104,05%
-90,42%
-1,49%
-0,20%
Earnings per share
0,75
0,95
0,89
0,90
Interest and investment income
12,00 млн
12,60 млн
10,00 млн
10,50 млн
Interest expense
-20,83 млн
-20,11 млн
-19,17 млн
-18,54 млн
Net interest expenses
-8,83 млн
-7,51 млн
-9,17 млн
-8,04 млн
Depreciation and amortization charges
-
-
-
-
EBITDA
85,94 млн
103,69 млн
94,82 млн
95,42 млн
Gain or loss from assets sale
281,00 м.
329,00 м.
-75,00 мың
843,00 м.
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google қолданбалары